Order a Bone Scan and CT Chest/Abdomen/Pelvis with IV Contrast
For a patient with ER-positive breast cancer presenting with left hip pain concerning for distant metastasis, you should order both a whole-body bone scan and CT chest/abdomen/pelvis with IV contrast. These are complementary studies that together provide comprehensive evaluation for distant recurrence 1.
Algorithmic Approach to Imaging
Primary Imaging Studies (Order Both)
1. Whole-Body Bone Scan
- This is the gold standard for detecting bone metastases in breast cancer
- ER-positive breast cancer has high propensity for bone metastases
- Bone scan is specifically recommended by NCCN guidelines for suspected distant recurrence 1
- Particularly sensitive for detecting multiple skeletal lesions that may not be symptomatic yet
2. CT Chest/Abdomen/Pelvis with IV Contrast
- NCCN guidelines specifically recommend bone scan PLUS CT chest/abdomen/pelvis for suspected distant recurrence 1
- Single-phase contrast-enhanced CT is sufficient to answer most clinical questions 1
- Evaluates for visceral metastases (liver, lung, lymph nodes) that commonly occur with bone metastases
- Provides anatomic detail of the symptomatic hip region
Alternative/Additional Imaging to Consider
FDG-PET/CT (Skull Base to Mid-Thigh)
- Also rated as "usually appropriate" for suspected distant recurrence 1
- Can be used in symptomatic patients with history of breast cancer treated with curative intent 1
- Important caveat: ER-positive tumors can be hypometabolic on FDG-PET, with 15-30% showing low uptake that may miss metastases 2
- Lower sensitivity in lobular histology and low-grade ER-positive tumors 2
Critical Clinical Pitfalls
The ER-Positive Imaging Challenge
ER-positive breast cancers present unique imaging challenges:
- They tend to be less FDG-avid than other subtypes, potentially leading to false negatives on PET 2
- Bone metastases from ER-positive disease are often detected better by bone scan than FDG-PET 3
- Up to 45% of patients may have heterogeneous metastases with variable tracer uptake 3
Don't Miss Visceral Disease
While the patient presents with hip pain suggesting bone metastasis, you must evaluate for synchronous visceral metastases:
- ER-positive breast cancer commonly has polymetastatic disease at presentation
- CT chest/abdomen/pelvis ensures you don't miss liver, lung, or nodal disease that would alter management
- This is why guidelines recommend BOTH bone scan AND CT, not either/or 1
Beware of "Bone Flare" Phenomenon
If the patient is already on treatment (particularly bone-directed therapy like denosumab), increased uptake on bone scan may represent pseudoprogression rather than true progression 4. Correlate imaging findings with clinical response and consider repeat imaging if uncertain.
Why Not Other Modalities?
Brain MRI: Not indicated unless neurologic symptoms present. Brain metastases are more common in HER2-positive and triple-negative subtypes, not ER-positive disease 1
FES-PET: While this estrogen receptor imaging can be valuable for assessing ER expression in metastases 3, 5, 6, it is not standard first-line imaging for suspected metastasis and has poor sensitivity for liver lesions 3. It's more useful for resolving diagnostic dilemmas after standard workup 3
CT without contrast: Inadequate for proper evaluation 1
The combination of bone scan plus contrast-enhanced CT chest/abdomen/pelvis provides the most comprehensive and guideline-concordant evaluation for this clinical scenario, maximizing detection of both osseous and visceral metastases that will determine prognosis and treatment strategy.